Loading company…
NovAliX, based in France, provides preclinical and clinical development services for drug candidates.
Founded in 2003 in France and originally established by Jean-Paul Renaud, NovAliX offers preclinical and clinical development services for drug candidates, working with research organizations to advance them through the pipeline. In 2023 it reported revenue of USD 23.26 mn and EBITDA of USD -734,205.7. The company has completed two funding deals, and Capital Grand Est has exited.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in